Acute retinal necrosis risk factors: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) |
Tarek Nafee (talk | contribs) |
||
| Line 7: | Line 7: | ||
==Risk Factors== | ==Risk Factors== | ||
Risk factors for the development of acute retinal necrosis (ARN) include: | Risk factors for the development of acute retinal necrosis (ARN) include:<ref name="ARNopth">{{cite journal| author=Chun HL, Missotten T, Salzmann J, Lightman SL | title=Acute Retinal Necrosis: Features, Management, and Outcomes | journal=Opthalmology | year=2007 | volume=114 | Issue=4 | pages=756-762 | url=http://www.sciencedirect.com/science/article/pii/S0161642006012073 }}</ref> | ||
*For Caucasian populations: possessing the HLA-DQw7, HLA-Bw62, and HLA-DR4 antigens<ref name="pmid2801857">{{cite journal |vauthors=Holland GN, Cornell PJ, Park MS, Barbetti A, Yuge J, Kreiger AE, Kaplan HJ, Pepose JS, Heckenlively JR, Culbertson WW |title=An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4 |journal=Am. J. Ophthalmol. |volume=108 |issue=4 |pages=370–4 |year=1989 |pmid=2801857 |doi= |url=}}</ref> | *For Caucasian populations: possessing the HLA-DQw7, HLA-Bw62, and HLA-DR4 antigens<ref name="pmid2801857">{{cite journal |vauthors=Holland GN, Cornell PJ, Park MS, Barbetti A, Yuge J, Kreiger AE, Kaplan HJ, Pepose JS, Heckenlively JR, Culbertson WW |title=An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4 |journal=Am. J. Ophthalmol. |volume=108 |issue=4 |pages=370–4 |year=1989 |pmid=2801857 |doi= |url=}}</ref> | ||
*For Japanese populations: possessing the HLA-Aw33, HLA-B44, and HLA-DRw6 antigens<ref name="pmid25356955">{{cite journal |vauthors=Brydak-Godowska J, Borkowski P, Szczepanik S, Moneta-Wielgoś J, Kęcik D |title=Clinical manifestation of self-limiting acute retinal necrosis |journal=Med. Sci. Monit. |volume=20 |issue= |pages=2088–96 |year=2014 |pmid=25356955 |pmc=4226315 |doi=10.12659/MSM.890469 |url=}}</ref> | *For Japanese populations: possessing the HLA-Aw33, HLA-B44, and HLA-DRw6 antigens<ref name="pmid25356955">{{cite journal |vauthors=Brydak-Godowska J, Borkowski P, Szczepanik S, Moneta-Wielgoś J, Kęcik D |title=Clinical manifestation of self-limiting acute retinal necrosis |journal=Med. Sci. Monit. |volume=20 |issue= |pages=2088–96 |year=2014 |pmid=25356955 |pmc=4226315 |doi=10.12659/MSM.890469 |url=}}</ref> | ||
Revision as of 13:51, 14 September 2016
|
Acute retinal necrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acute retinal necrosis risk factors On the Web |
|
American Roentgen Ray Society Images of Acute retinal necrosis risk factors |
|
Risk calculators and risk factors for Acute retinal necrosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
Overview
The primary risk factors for acute retinal necrosis include immunocompromised status and immunosuppression from disease and prolonged corticosteroid use. Genetic predisposition for certain Caucasian and Japanese populations can increase one's odds of developing acute retinal necrosis.
Risk Factors
Risk factors for the development of acute retinal necrosis (ARN) include:[1]
- For Caucasian populations: possessing the HLA-DQw7, HLA-Bw62, and HLA-DR4 antigens[2]
- For Japanese populations: possessing the HLA-Aw33, HLA-B44, and HLA-DRw6 antigens[3]
- Experiencing encephalitis from herpes simplex virus[4]
- Immunocompromised status from prior or concurrent disease[5]
- Immunosuppresion from extended corticosteroid therapy[6]
References
- ↑ Chun HL, Missotten T, Salzmann J, Lightman SL (2007). "Acute Retinal Necrosis: Features, Management, and Outcomes". Opthalmology. 114: 756–762. Unknown parameter
|Issue=ignored (|issue=suggested) (help) - ↑ Holland GN, Cornell PJ, Park MS, Barbetti A, Yuge J, Kreiger AE, Kaplan HJ, Pepose JS, Heckenlively JR, Culbertson WW (1989). "An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4". Am. J. Ophthalmol. 108 (4): 370–4. PMID 2801857.
- ↑ Brydak-Godowska J, Borkowski P, Szczepanik S, Moneta-Wielgoś J, Kęcik D (2014). "Clinical manifestation of self-limiting acute retinal necrosis". Med. Sci. Monit. 20: 2088–96. doi:10.12659/MSM.890469. PMC 4226315. PMID 25356955.
- ↑ Vandercam T, Hintzen RQ, de Boer JH, Van der Lelij A (2008). "Herpetic encephalitis is a risk factor for retinal necrosis". Neurology. 71 (16): 1268–74. doi:10.1212/01.wnl.0000327615.99124.99. PMID 18852442.
- ↑ Moutschen MP, Scheen AJ, Lefebvre PJ (1992). "Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections". Diabete Metab. 18 (3): 187–201. PMID 1397473.
- ↑ Yamamoto JH, Boletti DI, Nakashima Y, Hirata CE, Olivalves E, Shinzato MM, Okay TS, Santo RM, Duarte MI, Kalil J (2003). "Severe bilateral necrotising retinitis caused by Toxoplasma gondii in a patient with systemic lupus erythematosus and diabetes mellitus". Br J Ophthalmol. 87 (5): 651–2. PMC 1771672. PMID 12714420.